Falecalcitriol for conventional vitamin D therapy-resistant secondary hyperparathyroidism in a continuous ambulatory peritoneal dialysis patient.
M
M
Tokunaga
M
M
Tamura
N
N
Kabashima
R
R
Serino
T
T
Shibata
M
M
Matsumoto
T
T
Miyamoto
M
M
Miyazaki
Y
Y
Furuno
M
M
Takeuchi
H
H
Abe
M
M
Okazaki
Y
Y
Otsuji
D002117:Calcitriol / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004351:Drug Resistance; D006801:Humans; D006962:Hyperparathyroidism, Secondary / Q000188:drug therapy* / Q000209:etiology; D007676:Kidney Failure, Chronic / Q000150:complications; D008297:Male; D008875:Middle Aged; D010531:Peritoneal Dialysis, Continuous Ambulatory; D014807:Vitamin D / Q000627:therapeutic use*; D005466:Fluorocarbons
D002117:Calcitriol; D014807:Vitamin D; C040488:26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3; D005466:Fluorocarbons